Americas organic sales, orders, and backlog show recognized demand, new demand entering the pipeline, and accumulated contracted work, respectively.
Johnson Controls International plc
Company snapshot
A consistent view of the latest supported company value and reported operating results.
Fundamental lens
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is positive. As of 2026-03-31.
The retained reader does not currently have the required trailing-twelve-month fact.
Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-03-31.
Comparable retained change history is not available through this reader.
How this lens works
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Market summary
Completed-session reference prices from IEX for Oct 16, 2026.
Price statistics
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Price history
Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.
Derived reference metrics are omitted for this listing because the required history-quality checks did not clear for the full retained window.
About this market data
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.
Listing & sources
Ticker: JCI · Exchange: NYSE · Ordinary Shares, Par Value $0.01
SEC issuer CIK: 0000833444
Listing source refreshed: 2026-09-13
Financials
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
Income statement
| Metric | TTM · 2026-03-31 | FY 2025 · 2025-09-30 | FY 2025 · 2024-09-30 | FY 2025 · 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Revenue | $24.43B Filed 2026-05-06 | $23.6B Filed 2025-11-14 | $22.95B Filed 2025-11-14 | $22.33B Filed 2025-11-14 | $20.64B Filed 2024-11-19 |
| Cost of revenue | $15.5B Filed 2026-05-06 | $15B Filed 2025-11-14 | $14.88B Filed 2025-11-14 | $14.53B Filed 2025-11-14 | $13.55B Filed 2024-11-19 |
| Gross profit | $8.93B Filed 2026-05-06 | $8.59B Filed 2025-11-14 | $8.08B Filed 2025-11-14 | $7.8B Filed 2025-11-14 | $7.09B Filed 2024-11-19 |
| Pretax income | $2.51B Filed 2026-05-06 | $1.97B Filed 2025-11-14 | $1.52B Filed 2025-11-14 | $1.11B Filed 2025-11-14 | $1.11B Filed 2024-11-19 |
| Income tax expense | $450M Filed 2026-05-06 | $245M Filed 2025-11-14 | $111M Filed 2025-11-14 | -$468M Filed 2025-11-14 | -$182M Filed 2024-11-19 |
| Net income | $3.53B Filed 2026-05-06 | $3.29B Filed 2025-11-14 | $1.71B Filed 2025-11-14 | $1.85B Filed 2025-11-14 | $1.53B Filed 2024-11-19 |
| Diluted EPS | Unavailable | $5.03 Filed 2025-11-14 | $2.52 Filed 2025-11-14 | $2.69 Filed 2025-11-14 | $2.19 Filed 2024-11-19 |
| Diluted shares | Unavailable | 654.1M Filed 2025-11-14 | 676M Filed 2025-11-14 | 687.4M Filed 2025-11-14 | 699.6M Filed 2024-11-19 |
Balance sheet
| Metric | FY 2025 · 2025-09-30 | FY 2025 · 2024-09-30 | FY 2025 · 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Cash | $379M Filed 2025-11-14 | $606M Filed 2025-11-14 | $828M Filed 2025-11-14 | $2.03B Filed 2024-11-19 |
| Current assets | $10.16B Filed 2025-11-14 | $11.18B Filed 2025-11-14 | $10.74B Filed 2024-11-19 | $11.69B Filed 2023-12-14 |
| Current liabilities | $10.94B Filed 2025-11-14 | $11.96B Filed 2025-11-14 | $11.08B Filed 2024-11-19 | $11.24B Filed 2023-12-14 |
| Short-term borrowings | $723M Filed 2025-11-14 | $953M Filed 2025-11-14 | $361M Filed 2024-11-19 | $669M Filed 2023-12-14 |
| Total assets | $37.94B Filed 2025-11-14 | $42.7B Filed 2025-11-14 | $42.24B Filed 2024-11-19 | $42.16B Filed 2024-11-19 |
| Stockholders’ equity | $12.93B Filed 2025-11-14 | $16.1B Filed 2025-11-14 | $16.55B Filed 2024-11-19 | $16.27B Filed 2023-12-14 |
Cash flow
| Metric | TTM · 2026-03-31 | FY 2025 · 2025-09-30 | FY 2025 · 2024-09-30 | FY 2025 · 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Depreciation & amortization | $803M Filed 2026-05-06 | $865M Filed 2025-11-14 | $816M Filed 2025-11-14 | $745M Filed 2025-11-14 | $717M Filed 2024-11-19 |
| Capital expenditures | $372M Filed 2026-05-06 | $434M Filed 2025-11-14 | $494M Filed 2025-11-14 | $446M Filed 2025-11-14 | $487M Filed 2024-11-19 |
| Long-term debt repaid | Unknown | Unknown | Unknown | Unknown | $184M Filed 2022-11-15 |
| Dividends paid | $975M Filed 2026-05-06 | $976M Filed 2025-11-14 | $1B Filed 2025-11-14 | $980M Filed 2025-11-14 | $916M Filed 2024-11-19 |
| Stock repurchases | $5.55B Filed 2026-05-06 | $5.99B Filed 2025-11-14 | $1.25B Filed 2025-11-14 | $625M Filed 2025-11-14 | $1.44B Filed 2024-11-19 |
Calculated from the latest TTM financials
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Valuation
A supported valuation measure is not available from the current retained price, share-count, and financial inputs.
Statistics
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Ownership
No reviewed company-level insider ownership record is available for this listing.